POSTTEST AND EVALUATION FORM
Consensus on Care: Case Studies in the Management of Venous Thromboembolic
Events and Peripheral Neuropathy in Multiple Myeloma
September 30, 2010
Medical Education Resources and the International Myeloma Foundation Nurse Leadership Board
respect and appreciate your opinions. To assist us in evaluating the effectiveness of this activity
and to make recommendations for future educational offerings, please take a few minutes to
complete the posttest and evaluation form.
There are no prerequisites or fees for participating in and receiving credit for this activity.
Participants must 1) study the educational activity, 2) complete the posttest by recording the best
answer to each question in the answer key on this form, 3) complete the evaluation form, 4) mail or
fax the completed form to Medical Education Resources at
Medical Education Resources
1500 W. Canal Court, Building B
Littleton, CO 80120-6404
Fax: 720-449-0217
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a
completed posttest with a score of 70% or better. Statements of credit will be mailed within 6 weeks
of the activity.
Request for Credit
PLEASE PRINT
Name
Specialty
Organization
Degree
MD DO PA NP RN Other ___________
Mailing Address:
Hospital/Academic/Office
Home
Address:
City:
State:
Zip:
Telephone:
Fax:
Email:
Signature
Date:
I certify my actual time spent to complete this educational activity to be:
I participated in the entire activity and claim 1.0 credits.
I participated in only part of the activity and claim _____ credits.
Case Studies in the Management of Venous Thromboembolic
Events and Peripheral Neuropathy in Multiple Myeloma
Webinar Posttest
1. Patients with cancer are at risk for blood clots due to:
a. Stasis of blood flow from inactivity or immobility
b. Pro-coagulants secreted by the tumors
c. Vessel wall instability as a result of cancer treatment
d. Vascular compression from the tumor
e. All of the above
2. Signs of venous thromboembolism in MM include:
a. Bilateral swelling of upper extremities
b. Warm skin
c. Shortness of breath, cyanosis
d. Negative Homan's Sign
e. Low systemic temperature and bradycardia
3. The best test to identify blood clots in patients with MM is a skeletal survey
a. True/False
4. The best test to diagnose pulmonary embolism is a Spiral CT scan but this
should be used with caution in patients with MM
a. True/False
5. All patients receiving lenalidomide and thalidomide are at an increased risk for
venous thromboembolism (VTE). Nurses should be aware that risk of VTE:
a. Is increased in combination with pegylated liposomal doxorubicin
b. Is increased in patients with personal risk factors such as recent surgery,
obesity or prior history of blood clot
c. Can be life threatening
d. All of the above
6. The most effective management of mild (grade 1) bortezomib induced
peripheral neuropathy with pain includes:
a. Discontinue bortezomib and switch to another drug before the PN worsens
b. Hold bortezomib and restart at a reduced dose when the PN resolves
c. Continue with the current dose and schedule as the pain is likely to
resolve with time
d. Start oxycontin and oxycodone to manage the pain and continue current
dose
e. Start pregabalin and discontinue bortezomib if they are in remission
7. Which of these agent (s) may contribute to peripheral neuropathy (PN) in patients
with myeloma?
a. Bortezomib and thalidomide
b. Melphalan and prednisone
c. Lenalidomide
d. Pegylated liposomal doxorubicin
8. It is important for nurses to assess for side effects and appropriately manage
them to improve patient outcomes. Peripheral Neuropathy (PN) is a major side
effect of bortezomib. What are the recommendations for management of PN in
patients with progressive numbness in their feet with pain?
a. Continue to give bortezomib at the current dose
b. Instruct patients to apply cocoa butter to their feet and continue current
dose
c. Hold bortezomib until the symptoms resolve and continue at current dose
d. Hold bortezomib until the symptoms resolve and resume at reduced dose
Consensus on Care: Case Studies in the Management of Venous Thromboembolic
Events and Peripheral Neuropathy in Multiple Myeloma
Please answer the following questions by circling the appropriate rating:
5=Outstanding
4=Good
3=Satisfactory
2=Fair
1=Poor
Extent to Which Program Activities Met the Identified Objectives
After completing this activity, participants should be better able to:
5
4
3
2
1
Discuss critical issues in nursing management
Explore medical implications of major emergent side effects
5
4
3
2
1
Understand optimal management of emerging side effects
5
4
3
2
1
Discuss the International Myeloma Foundation's Nurse
5
4
3
2
1
Leadership Board Consensus Statements
Please indicate if this activity was free from commercial bias.
Yes
No
If No, please indicate the topic(s) that were not free from commercial bias.
_________________________________________________________________________________
Overall Effectiveness of the Activity
Objectives were related to overall purpose/goal(s) of activity.
5
4
3
2
1
Enhanced my current knowledge base.
5
4
3
2
1
Will help me improve patient care.
5
4
3
2
1
Provided new ideas or information I expect to use.
5
4
3
2
1
Was timely and will influence my practice of medicine.
5
4
3
2
1
Addressed my most pressing questions.
5
4
3
2
1
Please indicate any changes you plan to make in your practice of medicine as a result of information you
received from this activity.
____________________________________________________________________________________
____________________________________________________________________________________
Please provide general comments regarding this activity and suggest how it might be improved.
____________________________________________________________________________________
Please provide any other medical topics that would be of interest to you.
____________________________________________________________________________________